Tonghua Dongbao: Tonghua Dongbao Pharmaceutical Co., Ltd. is mainly engaged in Chinese and Western medicines, biological products and plastic building materials, etc. It is a key high-tech enterprise recognized by the Ministry of Science and Technology of the People's Republic of China under the Torch Plan. The company's "Dongbao" trademark has been recognized by the State Administration for Industry and Commerce as a well-known trademark in China. The company owns a series of products represented by recombinant human insulin (trade name: GANSULIN), and its product "GANSULIN" fills the blank in China, which makes China become the country that can produce recombinant human insulin and glycemic insulin after the United States and Denmark. In 2002, the scientific research achievement of recombinant human insulin won the Second Prize of the National Scientific and Technological Progress. In 2010, the industrialization of recombinant human insulin project declared by the company won the First Prize of Scientific and Technological Progress of Jilin Federation of Industry and Commerce and the First Prize of Scientific and Technological Progress of Tonghua City; recombinant human insulin injection Glycopyrrolimus 30R won the Famous-brand Product of Jilin Province.
East China Pharmaceutical: East China Pharmaceutical Co., Ltd. is a pharmaceutical production and pharmaceutical device manufacturing enterprise. The company's main products are mainly western and traditional Chinese medicine drugs, medical devices, etc. On January 17, 1997, the company changed its name to Hangzhou Huadong Pharmaceutical Co., Ltd. the company from a purely commercial enterprises in one fell swoop to become a set of pharmaceutical products production and sales network in one, the industry and commerce is closely integrated with the pharmaceutical production enterprises. 2010, the company's pharmaceutical business continues to maintain the leading position in the industry in Zhejiang Province.